Some technological and policy strategies for increasing organ supplies are ethically and legally proven to work. Consider best next steps for global education efforts to raise organ donation awareness.

Because transplantation for methylmalonic acidaemia prioritizes quality of life over long-term outcomes, justice and utility must be considered.

Equal access is a goal even when patients present with taboo illnesses. But, the date of a patient’s last drink still matters.

Heightened caution, improved physician and patient communication, and equitable access are key priorities.

Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks.

Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key.

Some clinicians offering image-guided procedures have little training in palliative medicine, which is both a clinical and an ethical problem.

Beatrice L. Brown joins Ethics Talk to discuss her article, coauthored with Dr Aaron S Kesselheim: "How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices?"

Dr Donna-Bea Tillman joins Ethics Talk to discuss her article: "What Should the Public Know About Implantable Material and Device Innovation in the US?"

Standards for posttransplant graft/survival rates do not reward transplant centers for performing riskier transplants to increase population benefit.